TRK-IN-14

TRK-IN-14

• CAS Number: 1365212-84-5
• UNSPSC Description: TRK-IN-14 is a potent inhibitor of TRK. Protein kinases play a critical role in the control of cell growth and differentiation and are responsible for the control of a wide variety of cellular signal transduction processes. TRK-IN-14 has the potential for the research of TRK-related diseases (extracted from patent WO2012034091A1, compound X-47)[1].
• Target Antigen: Trk Receptor
• Type: Reference compound
• Related Pathways: Neuronal Signaling;Protein Tyrosine Kinase/RTK
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/trk-in-14.html
• Solubility: 10 mM in DMSO
• Smiles: FC(C=C1)=CC=C1CNC(C2=CN=C3N2N=C(N4[C@](C5=CC(F)=CC=C5)([H])CCC4)C=C3)=O
• Molecular Weight: 433.45
• References & Citations: [1]Yi Fan, et al. Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors. Patent WO2012034091A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported